Click for best price
NonAlcoholic Steatohepatitis Treatment Market Size, Share 2023
Nonalcoholic steatohepatitis (NASH) is?inflammation of your liver caused by excess fat cells in it (fatty liver disease). Chronic inflammation causes progressive liver damage. NASH resembles hepatitis caused by alcohol use, but it stems from something else.
This report contains market size and forecasts of Non-Alcoholic Steatohepatitis Treatment in Global, including the following market information:
Global Non-Alcoholic Steatohepatitis Treatment Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Non-Alcoholic Steatohepatitis Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Vitamin E and Pioglitazone Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Non-Alcoholic Steatohepatitis Treatment include Intercept Pharmaceuticals, Galmed Pharmaceuticals, Inventiva Pharma, AbbVie Inc., Galectin Therapeutics Inc., Madrigal Pharmaceuticals, NGM Biopharmaceuticals Inc., Novo Nordisk A/S and Bristol Myers Squibb, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Non-Alcoholic Steatohepatitis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-Alcoholic Steatohepatitis Treatment Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Non-Alcoholic Steatohepatitis Treatment Market Segment Percentages, by Type, 2022 (%)
Vitamin E and Pioglitazone
Obeticholic Acid (OCA)
Lanifibranor
Semaglutide
Resmetirom
Aramchol
Cenicriviroc
Others
Global Non-Alcoholic Steatohepatitis Treatment Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Non-Alcoholic Steatohepatitis Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail & Specialty Pharmacies
Others
Global Non-Alcoholic Steatohepatitis Treatment Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Non-Alcoholic Steatohepatitis Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-Alcoholic Steatohepatitis Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Non-Alcoholic Steatohepatitis Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Intercept Pharmaceuticals
Galmed Pharmaceuticals
Inventiva Pharma
AbbVie Inc.
Galectin Therapeutics Inc.
Madrigal Pharmaceuticals
NGM Biopharmaceuticals Inc.
Novo Nordisk A/S
Bristol Myers Squibb
Gilead Sciences Inc.
| Report Attributes |
Report Details |
| Report Title |
Non-Alcoholic Steatohepatitis Treatment Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Non-Alcoholic Steatohepatitis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-Alcoholic Steatohepatitis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-Alcoholic Steatohepatitis Treatment Overall Market Size
2.1 Global Non-Alcoholic Steatohepatitis Treatment Market Size: 2022 VS 2030
2.2 Global Non-Alcoholic Steatohepatitis Treatment Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non-Alcoholic Steatohepatitis Treatment Players in Global Market
3.2 Top Global Non-Alcoholic Steatohepatitis Treatment Companies Ranked by Revenue
3.3 Global Non-Alcoholic Steatohepatitis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Non-Alcoholic Steatohepatitis Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Non-Alcoholic Steatohepatitis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-Alcoholic Steatohepatitis Treatment Players in Global Market
3.6.1 List of Global Tier 1 Non-Alcoholic Steatohepatitis Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-Alcoholic Steatohepatitis Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Non-Alcoholic Steatohepatitis Treatment Market Size Markets, 2022 & 2030
4.1.2 Vitamin E and Pioglitazone
4.1.3 Obeticholic Acid (OCA)
4.1.4 Lanifibranor
4.1.5 Semaglutide
4.1.6 Resmetirom
4.1.7 Aramchol
4.1.8 Cenicriviroc
4.1.9 Others
4.2 By Type - Global Non-Alcoholic Steatohepatitis Treatment Revenue & Forecasts
4.2.1 By Type - Global Non-Alcoholic Steatohepatitis Treatment Revenue, 2018-2023
4.2.2 By Type - Global Non-Alcoholic Steatohepatitis Treatment Revenue, 2023-2030
4.2.3 By Type - Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-Alcoholic Steatohepatitis Treatment Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail & Specialty Pharmacies
5.1.4 Others
5.2 By Application - Global Non-Alcoholic Steatohepatitis Treatment Revenue & Forecasts
5.2.1 By Application - Global Non-Alcoholic Steatohepatitis Treatment Revenue, 2018-2023
5.2.2 By Application - Global Non-Alcoholic Steatohepatitis Treatment Revenue, 2023-2030
5.2.3 By Application - Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Non-Alcoholic Steatohepatitis Treatment Market Size, 2022 & 2030
6.2 By Region - Global Non-Alcoholic Steatohepatitis Treatment Revenue & Forecasts
6.2.1 By Region - Global Non-Alcoholic Steatohepatitis Treatment Revenue, 2018-2023
6.2.2 By Region - Global Non-Alcoholic Steatohepatitis Treatment Revenue, 2023-2030
6.2.3 By Region - Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Non-Alcoholic Steatohepatitis Treatment Revenue, 2018-2030
6.3.2 US Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
6.3.3 Canada Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
6.3.4 Mexico Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Non-Alcoholic Steatohepatitis Treatment Revenue, 2018-2030
6.4.2 Germany Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
6.4.3 France Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
6.4.4 U.K. Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
6.4.5 Italy Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
6.4.6 Russia Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
6.4.7 Nordic Countries Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
6.4.8 Benelux Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Non-Alcoholic Steatohepatitis Treatment Revenue, 2018-2030
6.5.2 China Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
6.5.3 Japan Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
6.5.4 South Korea Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
6.5.5 Southeast Asia Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
6.5.6 India Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Non-Alcoholic Steatohepatitis Treatment Revenue, 2018-2030
6.6.2 Brazil Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
6.6.3 Argentina Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Revenue, 2018-2030
6.7.2 Turkey Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
6.7.3 Israel Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
6.7.4 Saudi Arabia Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
6.7.5 UAE Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2030
7 Players Profiles
7.1 Intercept Pharmaceuticals
7.1.1 Intercept Pharmaceuticals Corporate Summary
7.1.2 Intercept Pharmaceuticals Business Overview
7.1.3 Intercept Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Major Product Offerings
7.1.4 Intercept Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Revenue in Global Market (2018-2023)
7.1.5 Intercept Pharmaceuticals Key News
7.2 Galmed Pharmaceuticals
7.2.1 Galmed Pharmaceuticals Corporate Summary
7.2.2 Galmed Pharmaceuticals Business Overview
7.2.3 Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Major Product Offerings
7.2.4 Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Revenue in Global Market (2018-2023)
7.2.5 Galmed Pharmaceuticals Key News
7.3 Inventiva Pharma
7.3.1 Inventiva Pharma Corporate Summary
7.3.2 Inventiva Pharma Business Overview
7.3.3 Inventiva Pharma Non-Alcoholic Steatohepatitis Treatment Major Product Offerings
7.3.4 Inventiva Pharma Non-Alcoholic Steatohepatitis Treatment Revenue in Global Market (2018-2023)
7.3.5 Inventiva Pharma Key News
7.4 AbbVie Inc.
7.4.1 AbbVie Inc. Corporate Summary
7.4.2 AbbVie Inc. Business Overview
7.4.3 AbbVie Inc. Non-Alcoholic Steatohepatitis Treatment Major Product Offerings
7.4.4 AbbVie Inc. Non-Alcoholic Steatohepatitis Treatment Revenue in Global Market (2018-2023)
7.4.5 AbbVie Inc. Key News
7.5 Galectin Therapeutics Inc.
7.5.1 Galectin Therapeutics Inc. Corporate Summary
7.5.2 Galectin Therapeutics Inc. Business Overview
7.5.3 Galectin Therapeutics Inc. Non-Alcoholic Steatohepatitis Treatment Major Product Offerings
7.5.4 Galectin Therapeutics Inc. Non-Alcoholic Steatohepatitis Treatment Revenue in Global Market (2018-2023)
7.5.5 Galectin Therapeutics Inc. Key News
7.6 Madrigal Pharmaceuticals
7.6.1 Madrigal Pharmaceuticals Corporate Summary
7.6.2 Madrigal Pharmaceuticals Business Overview
7.6.3 Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Major Product Offerings
7.6.4 Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Revenue in Global Market (2018-2023)
7.6.5 Madrigal Pharmaceuticals Key News
7.7 NGM Biopharmaceuticals Inc.
7.7.1 NGM Biopharmaceuticals Inc. Corporate Summary
7.7.2 NGM Biopharmaceuticals Inc. Business Overview
7.7.3 NGM Biopharmaceuticals Inc. Non-Alcoholic Steatohepatitis Treatment Major Product Offerings
7.7.4 NGM Biopharmaceuticals Inc. Non-Alcoholic Steatohepatitis Treatment Revenue in Global Market (2018-2023)
7.7.5 NGM Biopharmaceuticals Inc. Key News
7.8 Novo Nordisk A/S
7.8.1 Novo Nordisk A/S Corporate Summary
7.8.2 Novo Nordisk A/S Business Overview
7.8.3 Novo Nordisk A/S Non-Alcoholic Steatohepatitis Treatment Major Product Offerings
7.8.4 Novo Nordisk A/S Non-Alcoholic Steatohepatitis Treatment Revenue in Global Market (2018-2023)
7.8.5 Novo Nordisk A/S Key News
7.9 Bristol Myers Squibb
7.9.1 Bristol Myers Squibb Corporate Summary
7.9.2 Bristol Myers Squibb Business Overview
7.9.3 Bristol Myers Squibb Non-Alcoholic Steatohepatitis Treatment Major Product Offerings
7.9.4 Bristol Myers Squibb Non-Alcoholic Steatohepatitis Treatment Revenue in Global Market (2018-2023)
7.9.5 Bristol Myers Squibb Key News
7.10 Gilead Sciences Inc.
7.10.1 Gilead Sciences Inc. Corporate Summary
7.10.2 Gilead Sciences Inc. Business Overview
7.10.3 Gilead Sciences Inc. Non-Alcoholic Steatohepatitis Treatment Major Product Offerings
7.10.4 Gilead Sciences Inc. Non-Alcoholic Steatohepatitis Treatment Revenue in Global Market (2018-2023)
7.10.5 Gilead Sciences Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Non-Alcoholic Steatohepatitis Treatment Market Opportunities & Trends in Global Market
Table 2. Non-Alcoholic Steatohepatitis Treatment Market Drivers in Global Market
Table 3. Non-Alcoholic Steatohepatitis Treatment Market Restraints in Global Market
Table 4. Key Players of Non-Alcoholic Steatohepatitis Treatment in Global Market
Table 5. Top Non-Alcoholic Steatohepatitis Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Non-Alcoholic Steatohepatitis Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Non-Alcoholic Steatohepatitis Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Non-Alcoholic Steatohepatitis Treatment Product Type
Table 9. List of Global Tier 1 Non-Alcoholic Steatohepatitis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-Alcoholic Steatohepatitis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Non-Alcoholic Steatohepatitis Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Non-Alcoholic Steatohepatitis Treatment Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Non-Alcoholic Steatohepatitis Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Non-Alcoholic Steatohepatitis Treatment Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023-2030
Table 30. Intercept Pharmaceuticals Corporate Summary
Table 31. Intercept Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Product Offerings
Table 32. Intercept Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), (2018-2023)
Table 33. Galmed Pharmaceuticals Corporate Summary
Table 34. Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Product Offerings
Table 35. Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), (2018-2023)
Table 36. Inventiva Pharma Corporate Summary
Table 37. Inventiva Pharma Non-Alcoholic Steatohepatitis Treatment Product Offerings
Table 38. Inventiva Pharma Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), (2018-2023)
Table 39. AbbVie Inc. Corporate Summary
Table 40. AbbVie Inc. Non-Alcoholic Steatohepatitis Treatment Product Offerings
Table 41. AbbVie Inc. Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), (2018-2023)
Table 42. Galectin Therapeutics Inc. Corporate Summary
Table 43. Galectin Therapeutics Inc. Non-Alcoholic Steatohepatitis Treatment Product Offerings
Table 44. Galectin Therapeutics Inc. Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), (2018-2023)
Table 45. Madrigal Pharmaceuticals Corporate Summary
Table 46. Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Product Offerings
Table 47. Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), (2018-2023)
Table 48. NGM Biopharmaceuticals Inc. Corporate Summary
Table 49. NGM Biopharmaceuticals Inc. Non-Alcoholic Steatohepatitis Treatment Product Offerings
Table 50. NGM Biopharmaceuticals Inc. Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), (2018-2023)
Table 51. Novo Nordisk A/S Corporate Summary
Table 52. Novo Nordisk A/S Non-Alcoholic Steatohepatitis Treatment Product Offerings
Table 53. Novo Nordisk A/S Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), (2018-2023)
Table 54. Bristol Myers Squibb Corporate Summary
Table 55. Bristol Myers Squibb Non-Alcoholic Steatohepatitis Treatment Product Offerings
Table 56. Bristol Myers Squibb Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), (2018-2023)
Table 57. Gilead Sciences Inc. Corporate Summary
Table 58. Gilead Sciences Inc. Non-Alcoholic Steatohepatitis Treatment Product Offerings
Table 59. Gilead Sciences Inc. Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Non-Alcoholic Steatohepatitis Treatment Segment by Type in 2022
Figure 2. Non-Alcoholic Steatohepatitis Treatment Segment by Application in 2022
Figure 3. Global Non-Alcoholic Steatohepatitis Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Non-Alcoholic Steatohepatitis Treatment Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Non-Alcoholic Steatohepatitis Treatment Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non-Alcoholic Steatohepatitis Treatment Revenue in 2022
Figure 8. By Type - Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2030
Figure 9. By Application - Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2030
Figure 10. By Region - Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2030
Figure 11. By Country - North America Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2030
Figure 12. US Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2030
Figure 16. Germany Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 17. France Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2030
Figure 24. China Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 28. India Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2030
Figure 30. Brazil Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2030
Figure 33. Turkey Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2030
Figure 37. Intercept Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Inventiva Pharma Non-Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. AbbVie Inc. Non-Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Galectin Therapeutics Inc. Non-Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. NGM Biopharmaceuticals Inc. Non-Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novo Nordisk A/S Non-Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bristol Myers Squibb Non-Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Gilead Sciences Inc. Non-Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
